Chondromodulin-1 directly suppresses growth of human cancer cells

Folkman J: Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg. 1972, 175 (3): 409-416. 10.1097/00000658-197203000-00014.

Jain S, Watson MA, DeBenedetti MK, Hiraki Y, Moley JF, Milbrandt J: Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors. Cancer Res. 2004, 64 (11): 3907-3913. 10.1158/0008-5472.CAN-03-3801.

Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, et al: Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors. J Clin Oncol. 2006, 24 (22): 3555-3561. 10.1200/JCO.2006.05.6762.

Hiraki Y, Tanaka H, Inoue H, Kondo J, Kamizono A, Suzuki F: Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes. Biochem Biophys Res Commun. 1991, 175 (3): 971-977. 10.1016/0006-291X(91)91660-5.

Hiraki Y, Inoue H, Iyama K, Kamizono A, Ochiai M, Shukunami C, Iijima S, Suzuki F, Kondo J: Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem. 1997, 272 (51): 32419-32426. 10.1074/jbc.272.51.32419.

Inoue H, Kondo J, Koike T, Shukunami C, Hiraki Y: Identification of an autocrine chondrocyte colony-stimulating factor: chondromodulin-I stimulates the colony formation of growth plate chondrocytes in agarose culture. Biochem Biophys Res Commun. 1997, 241 (2): 395-400. 10.1006/bbrc.1997.7820.

Hayami T, Shukunami C, Mitsui K, Endo N, Tokunaga K, Kondo J, Takahashi HE, Hiraki Y: Specific loss of chondromodulin-I gene expression in chondrosarcoma and the suppression of tumor angiogenesis and growth by its recombinant protein in vivo. FEBS Lett. 1999, 458 (3): 436-440. 10.1016/S0014-5793(99)01201-6.

Mori Y, Hiraki Y, Shukunami C, Kakudo S, Shiokawa M, Kagoshima M, Mano H, Hakeda Y, Kurokawa T, Suzuki F, et al: Stimulation of osteoblast proliferation by the cartilage-derived growth promoting factors chondromodulin-I and -II. FEBS Lett. 1997, 406 (3): 310-314. 10.1016/S0014-5793(97)00291-3.

Setoguchi K, Misaki Y, Kawahata K, Shimada K, Juji T, Tanaka S, Oda H, Shukunami C, Nishizaki Y, Hiraki Y, et al: Suppression of T cell responses by chondromodulin I, a cartilage-derived angiogenesis inhibitory factor: therapeutic potential in rheumatoid arthritis. Arthritis Rheum. 2004, 50 (3): 828-839. 10.1002/art.20193.

Schwartz MA: Integrins, oncogenes, and anchorage independence. J Cell Biol. 1997, 139 (3): 575-578. 10.1083/jcb.139.3.575.

Kato Y, Iwamoto M, Koike T: Fibroblast growth factor stimulates colony formation of differentiated chondrocytes in soft agar. J Cell Physiol. 1987, 133 (3): 491-498. 10.1002/jcp.1041330309.

Iwamoto M, Sato K, Nakashima K, Fuchihata H, Suzuki F, Kato Y: Regulation of colony formation of differentiated chondrocytes in soft agar by transforming growth factor-beta. Biochem Biophys Res Commun. 1989, 159 (3): 1006-1011. 10.1016/0006-291X(89)92208-0.

Aydelotte MB, Thonar EJ, Mollenhauer J, Flechtenmacher J: Culture of chondrocytes in alginate gel: variations in conditions of gelation influence the structure of the alginate gel, and the arrangement and morphology of proliferating chondrocytes. In Vitro Cell Dev Biol Anim. 1998, 34 (2): 123-130. 10.1007/s11626-998-0094-x.

Seyedin SM, Thompson AY, Bentz H, Rosen DM, McPherson JM, Conti A, Siegel NR, Galluppi GR, Piez KA: Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J Biol Chem. 1986, 261 (13): 5693-5695.

Urashima M, Hoshi Y, Shishikura A, Kamijo M, Kato Y, Akatsuka J, Maekawa K: Umbilical cord blood as a rich source of immature hematopoietic stem cells. Acta Paediatr Jpn. 1994, 36 (6): 649-655.

Avraham S, Avraham H: Characterization of the novel focal adhesion kinase RAFTK in hematopoietic cells. Leuk Lymphoma. 1997, 27 (3–4): 247-256.

Kleeff J, Maruyama H, Friess H, Buchler MW, Falb D, Korc M: Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer. Biochem Biophys Res Commun. 1999, 255 (2): 268-273. 10.1006/bbrc.1999.0171.

Kleeff J, Ishiwata T, Maruyama H, Friess H, Truong P, Buchler MW, Falb D, Korc M: The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene. 1999, 18 (39): 5363-5372. 10.1038/sj.onc.1202909.

Peng B, Fleming JB, Breslin T, Grau AM, Fojioka S, Abbruzzese JL, Evans DB, Ayers D, Wathen K, Wu T, et al: Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. Clin Cancer Res. 2002, 8 (11): 3628-3638.

Schwartz MA, Assoian RK: Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci. 2001, 114 (Pt 14): 2553-2560.

Schwartz MA, Ginsberg MH: Networks and crosstalk: integrin signalling spreads. Nat Cell Biol. 2002, 4 (4): E65-68. 10.1038/ncb0402-e65.

Walker JL, Assoian RK: Integrin-dependent signal transduction regulating cyclin D1 expression and G1 phase cell cycle progression. Cancer Metastasis Rev. 2005, 24 (3): 383-393. 10.1007/s10555-005-5130-7.

Besser D, Bromberg JF, Darnell JE, Hanafusa H: A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol Cell Biol. 1999, 19 (2): 1401-1409.

Bromberg JF: Activation of STAT proteins and growth control. Bioessays. 2001, 23 (2): 161-169. 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0.

Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, et al: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 2002, 21 (13): 2000-2008. 10.1038/sj.onc.1205260.

Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA: JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia. 2004, 18 (2): 189-218. 10.1038/sj.leu.2403241.

Klampfer L: Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs. Curr Cancer Drug Targets. 2006, 6 (2): 107-121. 10.2174/156800906776056491.

Hiraki Y, Mitsui K, Endo N, Takahashi K, Hayami T, Inoue H, Shukunami C, Tokunaga K, Kono T, Yamada M, et al: Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells. Eur J Biochem. 1999, 260 (3): 869-878. 10.1046/j.1432-1327.1999.00227.x.

Hotta T, Motoyama T, Watanabe H: Three human osteosarcoma cell lines exhibiting different phenotypic expressions. Acta Pathol Jpn. 1992, 42 (8): 595-603.

Motoyama T, Hotta T, Watanabe H, Kumanishi T, Ichikawa T, Sekiguchi M: Differential production of interleukin 6 in human osteosarcoma cells and the possible effects on neoplastic bone metabolism. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993, 63 (5): 277-281. 10.1007/BF02899273.

Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I: Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA. 1996, 93 (3): 1320-1324. 10.1073/pnas.93.3.1320.

Hiraki Y, Shukunami C: Angiogenesis inhibitors localized in hypovascular mesenchymal tissues: chondromodulin-I and tenomodulin. Connect Tissue Res. 2005, 46 (1): 3-11. 10.1080/03008200590935547.

Azizan A, Gaw JU, Govindraj P, Tapp H, Neame PJ: Chondromodulin I and pleiotrophin gene expression in bovine cartilage and epiphysis. Matrix Biol. 2000, 19 (6): 521-531. 10.1016/S0945-053X(00)00110-4.

Nakamichi Y, Shukunami C, Yamada T, Aihara K, Kawano H, Sato T, Nishizaki Y, Yamamoto Y, Shindo M, Yoshimura K, et al: Chondromodulin I is a bone remodeling factor. Mol Cell Biol. 2003, 23 (2): 636-644. 10.1128/MCB.23.2.636-644.2003.

Starr R, Hilton DJ: Negative regulation of the JAK/STAT pathway. Bioessays. 1999, 21 (1): 47-52. 10.1002/(SICI)1521-1878(199901)21:1<47::AID-BIES6>3.0.CO;2-N.

Yoshioka M, Yuasa S, Matsumura K, Kimura K, Shiomi T, Kimura N, Shukunami C, Okada Y, Mukai M, Shin H, et al: Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med. 2006, 12 (10): 1151-1159. 10.1038/nm1476.